Corrigendum to "Inhibition of AKT sensitizes chemoresistant ovarian cancer cells to cisplatin by abrogating S and G2/M arrest" (Exp. Mol. Pathol. 2016 100(3) 506-13).

Di Zhang Hai-Lan Piao Yan-Hong Li Qing Qiu Da-Jin Li Mei-Rong Du Benjamin K Tsang

Exp Mol Pathol

State Key Laboratory of Quality Research in Chinese Medicine and the Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau; Department of Obstetrics and Gynecology, Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, Canada; Department of Cellular and Molecular Medicine, Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, Canada; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Canada.

Published: August 2016

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.yexmp.2016.06.004	DOI Listing

Publication Analysis

Top Keywords

corrigendum "inhibition

"inhibition akt

akt sensitizes

sensitizes chemoresistant

chemoresistant ovarian

ovarian cancer

cancer cells

cells cisplatin

cisplatin abrogating

abrogating g2/m

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!